Many people who have stopped taking GLP-1s end up gaining weight back
She take the time to listen, Cameron Garcia Highly recommend
Microdosingessentially, taking a smaller dose of something than is normally prescribedhas taken off among some users of GLP-1 medications, including semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro)
This hormonal transition often begins in your late 30s or early 40s long before full menopause
Individual results vary based on genetics, lifestyle adherence, starting weight, and dose escalation
Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity